DeepRhythmAI vs KardiaAI
AI Verdict
Choose DeepRhythmAI if…
Choose DeepRhythmAI if your healthcare system or cardiology practice requires a comprehensive, high-throughput, cloud-based AI solution for analyzing ECG data from diverse devices. This tool is ideal for significantly improving diagnostic accuracy and efficiency across a large volume of patients, aiming to reduce missed diagnoses and streamline clinical workflows at an enterprise level.
View DeepRhythmAI →Choose KardiaAI if…
Choose KardiaAI if you are a developer or a healthcare provider looking to integrate an FDA-cleared AI-powered ECG analysis library into existing mobile applications, web platforms, or ambulatory ECG devices. This solution is best suited for adding robust detection capabilities for conditions like AFib, bradycardia, and tachycardia to your own patient monitoring or clinical applications, often with a subscription-based model for integrated services.
View KardiaAI →When choosing between DeepRhythmAI and KardiaAI, physicians should consider their primary workflow and integration needs. DeepRhythmAI, offered by Medicalgorithmics S.A., is a cloud-based AI algorithm designed for comprehensive cardiac arrhythmia detection and classification from ECG data. It boasts superior accuracy, leveraging CNN and Transformer models trained on over 250 billion annotated heartbeats, and is device-agnostic, integrating with various ECG devices. Its strengths lie in its ability to significantly reduce missed diagnoses and streamline clinical workflows, making it ideal for practices seeking a robust, high-throughput solution for detailed ECG analysis across a wide range of devices.
In contrast, KardiaAI by AliveCor is an FDA-cleared AI software library primarily focused on analyzing ambulatory ECG rhythms. It offers detection of conditions like AFib, bradycardia, and tachycardia, as well as specific rhythm characteristics such as premature ventricular contractions and supraventricular ectopy. KardiaAI is deployed as a Software as a Medical Device (SaMD) and is available as an API library for integration into mobile apps and web platforms, with subscription-based pricing for integrated services like KardiaCare. The key practical difference lies in their deployment and integration models: DeepRhythmAI is a standalone cloud solution for comprehensive analysis, while KardiaAI is an embeddable library best suited for integration into existing mobile or web-based ECG monitoring solutions. Physicians prioritizing a dedicated, high-volume ECG analysis platform that can integrate with diverse devices may lean towards DeepRhythmAI. Conversely, those looking to enhance their current mobile or web-based ECG monitoring tools with an AI-powered analysis library, particularly for ambulatory rhythm detection, would find KardiaAI more suitable.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepRhythmAI | KardiaAI |
|---|---|---|
| Pricing | Enterprise | Subscription-based for integrated services |
| Deployment | Cloud | Software as a Medical Device (SaMD), API library integrated into mobile apps and web platforms |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaAIKardiaAI, through AliveCor's KardiaMobile devices and associated app, offers a highly user-friendly experience for patients, with over 93% finding it easy to use and reducing anxiety [17]. While DeepRhythmAI integrates into workflows and offers a platform with an intuitive UI, KardiaAI's direct patient-facing usability and established consumer ecosystem provide a stronger advantage in this dimension [2, 9, 18, 31].
Clinical Value
DeepRhythmAIDeepRhythmAI demonstrates superior clinical value with claims of reducing missed diagnoses by 14x to 114x compared to human analysis, validated by the independent DRAIMARTINI study published in Nature Medicine [1, 7, 10, 22, 29, 30, 35]. Its training on over 250 billion annotated heartbeats and a 99.9% negative predictive value for critical arrhythmias further underscore its high accuracy and reliability [1, 7, 10, 30].
Pricing & Value
KardiaAIKardiaAI offers transparent, subscription-based pricing for its KardiaCare services, providing clear cost information for individual users and integrated services [JSON]. DeepRhythmAI's pricing is listed as 'enterprise' with 'Unknown' details, making it difficult to assess its value proposition without specific cost information [JSON].
Enterprise Readiness
KardiaAIKardiaAI explicitly states HIPAA compliance, BAA availability, and SOC2 Type 1 and Type 2 attestations, along with ISO 27001 Certification, which are crucial for enterprise healthcare deployments [15, 16, 33]. While DeepRhythmAI is cloud-based with an API and targets large health systems, its core AI's explicit HIPAA/BAA compliance is not as clearly detailed in the provided facts as for KardiaAI, though its DeepRhythm Platform is ISO 27001 certified [31].
Innovation
DeepRhythmAIDeepRhythmAI showcases strong innovation by explicitly utilizing advanced CNN and Transformer models and being trained on an exceptionally large dataset of over 250 billion annotated heartbeats [1, 7]. It is also highlighted as the first and only FDA-cleared AI algorithm solution intended for integration with third-party software under the QYX product code, indicating a pioneering regulatory achievement [1, 5].
Support & Docs
KardiaAIWhile neither JSON provides extensive details, AliveCor's broader ecosystem for KardiaAI includes mentions of developer support and API documentation for integrators on its website, suggesting a more established resource base for technical assistance [18]. DeepRhythmAI's available information is less specific regarding dedicated support and documentation for its integration solution.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepRhythmAI | KardiaAI |
|---|---|---|
| Name | DeepRhythmAI | KardiaAI |
| Company | Medicalgorithmics S.A. | AliveCor |
| Description | FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Key Features (Arrhythmia Detection) | AI-powered arrhythmia detection and classification, utilizes CNN and Transformer models, trained on 250 billion+ annotated heartbeats, reduces missed diagnoses (14x to 114x fewer). | AI-powered ECG analysis library, detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE). |
| API Available | yes | yes |
| Target Size | Solo to large health systems | Not specified |
| Specialties | Cardiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring DeepRhythmAI and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring DeepRhythmAI or KardiaAI
Backers
Who funded each tool's parent company.